ANOTHER BROWN STUDY FOUND THE USE OF ANTI-OBESITY MEDS MORE THAN DOUBLED FROM 2022 TO 2023, WHILE BARIATRIC SURGERIES DECREASED 25.6%.
JFM.25 Obesity meds bit
ANOTHER BROWN STUDY FOUND THE USE OF ANTI-OBESITY MEDS MORE THAN DOUBLED FROM 2022 TO 2023, WHILE BARIATRIC SURGERIES DECREASED 25.6%.